Agile Therapeutics | AGRX - Current Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Agile Therapeutics

Agile Therapeutics reported $10.91M in Current Assets for its fiscal quarter ending in March of 2023.


Current Assets Change
Adma Biologics ADMA:US USD 264.09M 6.32M
Agile Therapeutics AGRX:US USD 10.91M 452K
Bayer BAYN:GR EUR 39.62B 1.86B
BioMarin Pharmaceutical BMRN:US USD 2.84B 90.65M
J&J JNJ:US USD 64.39B 9.09B
Pacira PCRX:US USD 376.11M 122.22M
TherapeuticsMD TXMD:US USD 24.74M 30.62M